PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 2013090
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 2013090
Robotic Surgery Market size was valued at US$ 13,781.76 Million in 2025, expanding at a CAGR of 16.55% from 2026 to 2033.
Remote surgery is an advanced medical technology that allows surgeons to perform operations on patients from a distant location. It uses robotic systems, high-speed communication networks, and imaging technologies to carry out surgical procedures remotely. With the help of these systems, surgeons can control surgical instruments and monitor the procedure without being physically present in the same operating room.
This market belongs to the wider healthcare technology sector that aims to improve medical services and patient access to specialized care. It includes different tools, robotic platforms, and communication systems that support remote surgical procedures. For instance, in November 2024, according to the Private Healthcare Information Network, 22,700 robot-assisted surgeries were performed in the first quarter of 2024, a 45% increase compared with the same period in 2023, while procedures across the National Health Service and private sector grew by 524% between 2016 and 2023, highlighting the rapid expansion of advanced surgical technologies. This trend highlights the rapid adoption of robotic surgical technologies and the growing integration of advanced digital tools in modern healthcare systems.
Robotic Surgery Market- Market Dynamics
Rising Use Of Advanced Surgical Systems Driving Market Growth
Rising surgical volumes worldwide are fueling growth in the remote surgery market, driven by aging populations, chronic diseases, and better access to healthcare. Hospitals are increasingly adopting advanced technologies to improve surgical accuracy, efficiency, and patient outcomes. Remote surgery systems, using robotic platforms and high-speed networks, allow surgeons to perform procedures with greater precision and visualization. As healthcare providers focus on enhancing surgical performance and expanding specialist access, the adoption of these technologies continues to rise, boosting market growth. For instance, in August 2023, according to The Aesthetic Society, a US-based organization, Americans spent more than $11.8 billion on aesthetic procedures, representing a 2% increase from the previous year, reflecting the growing number of advanced surgical procedures worldwide. Therefore, the rising number of surgeries across the globe is driving the growth of the remote surgeries industry.
The Global Robotic Surgery Market is segmented on the basis of Applications, Offering, End User, and Region.
In terms of applications, the general surgery segment is expected to hold the most significant position in the remote surgery market because general surgeries make up a large share of procedures performed worldwide. These surgeries require high precision, improved visualization, and minimally invasive techniques, making remote surgery systems especially valuable. The growing need for safe, efficient, and accurate surgical outcomes further drives the adoption of robotic and remote surgical technologies in this segment. For instance, India's rapidly expanding healthcare sector, the minimally invasive surgery (MIS) industry, is witnessing significant growth. By 2025, higher incomes, better hospital infrastructure, and affordable robotic solutions with surgeon training are driving nationwide MIS adoption. The increasing demand for precision, minimally invasive procedures, and advanced surgical technologies is driving strong growth in the remote surgery and MIS markets.
The market is organized into offerings, including Products (Robotics System, Laparoscopic Robotic System, Orthopedic Robotic System, Neurosurgical Robotic System, and Other Robotic Systems) and Services. Robotics systems dominate the market due to their ability to enhance surgical precision, reduce invasiveness, and improve patient recovery. These systems enable surgeons to perform complex procedures with higher precision across specialties, while advanced imaging and navigation technologies streamline workflows, reduce complications, and improve patient outcomes. For instance, in November 2023, it was announced that an investigational device exemption (IDE) would be sought from the U.S. Food & Drug Administration (FDA) for the OTTAVA robotics systems, with plans to apply in the second half of 2024, paving the way for clinical trials to begin. The increasing integration of robotics systems in surgery is enhancing precision, patient outcomes, and clinical workflow efficiency across multiple specialties.
Robotic Surgery Market- Geographical Insights
The robotic surgery market is strongly influenced by geographical factors, particularly in regions with advanced healthcare systems and strict medical regulations. North America is set to maintain a leading position, driven by its robust regulatory standards and focus on enhancing patient safety and surgical outcomes. For instance, in February 2026, according to FACS.org, a report on robotic surgery highlighted that regulatory bodies like the U.S. The FDA, EU agencies, and Japan classify robotics systems as medical devices, and policymakers in several industrialized nations are actively exploring more stringent oversight frameworks and autonomy-based classifications to address emerging risks and ensure safe, regulated use of robotic surgical technologies. Strong regulatory frameworks and advanced healthcare infrastructure are driving the safe adoption and growth of robotic surgery worldwide.
Beyond North America, Asia-Pacific region is becoming a major player in the robotic surgery market, with rapid growth in healthcare infrastructure, rising adoption of advanced surgical technologies, and favorable government support and investments driving its increasing influence in the global landscape. In May 2023, government support is evident as AIIMS New Delhi partnered with Medtronic India to launch an advanced surgical robotics training center at AIIMS. The center will offer comprehensive training programs, encompassing a range of skills from basic robotic surgery techniques to specialized methods in soft-tissue surgery, designed to enhance expertise in robotic-assisted surgery (RAS). Expanding healthcare infrastructure, advanced surgical technology adoption, and government support are driving Asia-Pacific's rise in the global robotic surgery market.
U.S Robotic Surgery Market- Country Insights
In the robotic surgery market, strong U.S. healthcare regulations and an emphasis on medical technology advancement support the adoption and integration of cutting-edge robotic AI surgical systems. In September 2023, the Canady Robotic AI Surgical System was introduced by US Medical Innovations (USMI) in collaboration with the Jerome Canady Research Institute (JCRI-ABTS). As the world's first AI-driven robotic system combining cold atmospheric plasma (CAP) with a 3D non-contact bioelectric pulsed electromagnetic field, this innovation is expected to significantly drive growth in the robotic surgery market. These advancements highlight the U.S.'s leading role in driving innovation, adoption, and market growth in robotic-assisted surgical technologies.
Rising demand for minimally invasive procedures and improved surgical accuracy is driving innovation in the robotic surgery market. Collaborations between medical device manufacturers, healthcare providers, and technology companies are accelerating the development of advanced robotic-assisted surgical systems. Key players such as Intuitive Surgical, Medtronic, Stryker Corporation, Zimmer Biomet, and Johnson & Johnson are focusing on next-generation robotic platforms, AI-assisted technologies, and real-time imaging capabilities. Ongoing research, product development, and digital integration are supporting wider adoption of robotic surgery in hospitals while improving patient outcomes and surgical efficiency worldwide. For example, in 2024, Intuitive Surgical continued expanding its da Vinci robotic surgery platform, introducing advanced imaging, enhanced instrument control, and digital integration features to improve surgical precision and support minimally invasive procedures across hospitals worldwide.
In October 2025, Zimmer Biomet completed the acquisition of Monogram Technologies, an AI-driven orthopedic robotics company, to expand its robotic surgery portfolio. The acquisition integrates Monogram's semi- and fully autonomous robotic technologies with Zimmer Biomet's ROSA(R) robotics platform, strengthening the company's capabilities in advanced robotic-assisted orthopedic procedures and accelerating the development of autonomous surgical robotics.
In April 2025, Johnson & Johnson announced the completion of the first clinical cases using its OTTAVA Robotic Surgical System during a clinical trial in the United States. The milestone demonstrated the system's ability to support complex minimally invasive procedures and marked a key step toward the commercialization of the multi-specialty robotic surgery platform.